Geode Capital Management
OCDX

Geode Capital Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Geode Capital Management’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,139,751
Closed -$39.9M – 5066
2022
Q1 		$39.9M Sell
2,139,751
-348,563
-14% -$6.27M 0.01% 1406
2021
Q4 		$53.2M Buy
2,488,314
+19,996
+0.8% +$394K 0.01% 1262
2021
Q3 		$45.6M Buy
2,468,318
+960,962
+64% +$19.3M 0.01% 1355
2021
Q2 		$32.3M Buy
1,507,356
+48,806
+3% +$992K ﹤0.01% 1660
2021
Q1 		$28.1M Buy
+1,458,550
New +$25.7M ﹤0.01% 1661

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Geode Capital Management's OCDX Position: Q2 2022 in Review

Geode Capital Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 2,139,751 shares — an estimated $39.9M sold.

Geode Capital Management first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $53.2M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Geode Capital Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Geode Capital Management sold 2,139,751 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $39.9M.
  • Geode Capital Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
  • Geode Capital Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $53.2M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Geode Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.